The Secondary Resistome of Methicillin-Resistant <i>Staphylococcus aureus</i> to β-Lactam Antibiotics
<b>Background</b>: Therapeutic strategies for methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) are increasingly limited due to the ability of the pathogen to evade conventional treatments such as vancomycin and daptomycin. This challenge has shifted the focus towards novel strategies, inclu...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI AG
2025-01-01
|
| Edice: | Antibiotics |
| Témata: | |
| On-line přístup: | https://www.mdpi.com/2079-6382/14/2/112 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
